Indivior Pharmaceuticals, Inc. — All Filings
503 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-Q
144
15-12G
20-F
20FR12B
20FR12B/A
3
4
6-K
6-K/A
8-K
8-K/A
ARS
CERT
CORRESP
DEF 14A
DEFA14A
DFAN14A
DRS
DRS/A
DRSLTR
EFFECT
F-6
S-8
S-8 POS
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF ACTION
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 3 | FORM 3 | 0001257599-26-000002 | Jan 7, 2026 | Jan 1, 2026 |
| 3 | FORM 3 | 0001827169-26-000002 | Jan 7, 2026 | Jan 1, 2026 |
| 4 | FORM 4 | 0001789507-26-000004 | Jan 7, 2026 | Jan 5, 2026 |
| 3 | FORM 3 | 0001733376-26-000002 | Jan 7, 2026 | Jan 1, 2026 |
| 4 | FORM 4 | 0001257599-26-000004 | Jan 7, 2026 | Jan 5, 2026 |
| 4 | FORM 4 | 0001487937-26-000004 | Jan 7, 2026 | Jan 5, 2026 |
| 4 | FORM 4 | 0002014900-26-000004 | Jan 7, 2026 | Jan 5, 2026 |
| SCHEDULE 13D/A | — | 0001140361-25-046912 | Dec 30, 2025 | — |
| SCHEDULE 13D/A | — | 0001315863-25-000874 | Dec 23, 2025 | — |
| 8-K | 8-K | 0001625297-25-000078 | Dec 22, 2025 | — |
| SCHEDULE 13G | — | 0001104659-25-123739 | Dec 22, 2025 | — |
| 8-K | 8-K | 0001625297-25-000076 | Dec 18, 2025 | Dec 12, 2025 |
| 8-K | 8-K | 0001625297-25-000072 | Dec 15, 2025 | Dec 11, 2025 |
| SCHEDULE 13D/A | — | 0001011438-25-000594 | Dec 10, 2025 | — |
| 8-K | 8-K | 0001625297-25-000069 | Nov 20, 2025 | — |
| 8-K | 8-K | 0001628280-25-052210 | Nov 14, 2025 | — |
| SCHEDULE 13G/A | — | 0001193805-25-001583 | Nov 13, 2025 | — |
| SCHEDULE 13D/A | — | 0001140361-25-042045 | Nov 13, 2025 | — |
| 144 | — | 0001972481-25-000264 | Nov 7, 2025 | — |
| SCHEDULE 13D/A | — | 0001011438-25-000504 | Nov 5, 2025 | — |
| 8-K/A | 8-K/A | 0001625297-25-000064 | Oct 30, 2025 | Aug 26, 2025 |
| 8-K | 8-K | 0001193125-25-257381 | Oct 30, 2025 | — |
| 10-Q | 10-Q | 0001628280-25-047530 | Oct 30, 2025 | Sep 30, 2025 |
| 8-K | 8-K | 0001628280-25-043293 | Oct 1, 2025 | — |
| 144 | — | 0001974494-25-000101 | Sep 8, 2025 | — |
| 144 | — | 0002007317-25-001045 | Sep 8, 2025 | — |
| SCHEDULE 13D/A | — | 0001011438-25-000461 | Sep 5, 2025 | — |
| 144 | — | 0001974494-25-000099 | Sep 4, 2025 | — |
| 144 | — | 0001974494-25-000091 | Aug 28, 2025 | — |
| 8-K | 8-K | 0001625297-25-000059 | Aug 26, 2025 | — |
| 8-K | 8-K | 0001625297-25-000056 | Aug 22, 2025 | Aug 20, 2025 |
| 8-K/A | 8-K/A | 0001628280-25-037425 | Aug 4, 2025 | Jun 20, 2025 |
| 8-K | 8-K | 0001193125-25-169947 | Jul 31, 2025 | — |
| 10-Q | 10-Q | 0001625297-25-000050 | Jul 31, 2025 | Jun 30, 2025 |
| SCHEDULE 13D/A | — | 0001011438-25-000384 | Jul 29, 2025 | — |
| SCHEDULE 13G | — | 0002052113-25-002967 | Jul 17, 2025 | — |
| SCHEDULE 13D/A | — | 0001011438-25-000346 | Jul 14, 2025 | — |
| 8-K | 8-K | 0001625297-25-000046 | Jun 30, 2025 | — |
| 8-K | 8-K | 0001625297-25-000042 | Jun 24, 2025 | Jun 20, 2025 |
| SCHEDULE 13D/A | — | 0001315863-25-000466 | Jun 18, 2025 | — |
| 8-K | 8-K | 0001625297-25-000035 | Jun 2, 2025 | May 30, 2025 |
| 8-K | 8-K | 0001193125-25-132699 | Jun 2, 2025 | — |
| SCHEDULE 13D/A | — | 0001011438-25-000331 | May 22, 2025 | — |
| SCHEDULE 13G/A | — | 0001193805-25-000648 | May 13, 2025 | — |
| 8-K/A | 8-K/A | 0001193125-25-116997 | May 12, 2025 | May 8, 2025 |
| 8-K | 8-K | 0001625297-25-000032 | May 8, 2025 | — |
| 10-Q | 10-Q | 0001625297-25-000030 | May 1, 2025 | Mar 31, 2025 |
| 8-K | 8-K | 0001193125-25-091736 | Apr 24, 2025 | — |
| 8-K | 8-K | 0001625297-25-000025 | Mar 27, 2025 | — |
| ARS | ARS | 0001193125-25-059274 | Mar 20, 2025 | Dec 31, 2024 |